Vident Advisory’s MetLife MET Stock Holding History

Vident Advisory’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11M	Sell	24,906 -1,032	-4%	-$83.2K	0.02%	677
2026 Q1	$1.83M	Buy	25,938 +5,901	+29%	+$442K	0.02%	649
2025 Q4	$1.58M	Sell	20,037 -591	-3%	-$46.8K	0.01%	648
2025 Q3	$1.7M	Buy	20,628 +1,363	+7%	+$107K	0.02%	627
2025 Q2	$1.55M	Buy	19,265 +1,415	+8%	+$109K	0.02%	594
2025 Q1	$1.43M	Buy	17,850 +4,290	+32%	+$357K	0.02%	591
2024 Q4	$1.11M	Buy	13,560 +1,485	+12%	+$124K	0.02%	605
2024 Q3	$996K	Buy	12,075 +2,036	+20%	+$152K	0.03%	632
2024 Q2	$705K	Buy	10,039 +1,628	+19%	+$116K	0.02%	725
2024 Q1	$623K	Buy	8,411 +53	+0.6%	+$3.69K	0.01%	732
2023 Q4	$553K	Buy	8,358 +866	+12%	+$54.2K	0.01%	747
2023 Q3	$471K	Buy	+7,492	New	+$467K	0.01%	723

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vident Advisory's MET Position: Q2 2026 in Review

Vident Advisory reduced its MetLife (MET) stake by 4% in Q2 2026, selling an estimated $83.2K and leaving 24,906 shares worth $2.11M. The position accounts for 0.02% of the portfolio, ranked #677.

Vident Advisory first reported a position in MET in Q3 2023 and has held it in 12 quarters since. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

Vident Advisory held 24,906 shares of MetLife worth $2.11M as of Q2 2026.
Vident Advisory sold 1,032 MetLife shares in Q2 2026, an estimated $83.2K.
MetLife made up 0.02% of Vident Advisory's portfolio in Q2 2026, its #677 holding.
Vident Advisory first reported a position in MetLife in Q3 2023 and has held it in 12 quarters since.
1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.